Xylosyltransferase (XylT) (EC 2.4.2.26) initiates the biosynthesis of glycosaminoglycan (GAG) chains characteristic of proteoglycans by transfer of xylose (Xyl) from UDP-Xyl to specific serine residues of the core protein (Fig. 1). Thus, it is suggested that XylT is a rate-limitting enzyme in GAG synthesis. XylT-I and XylT-II genes encode XylT in humans*. So far, it has been shown that XylT activities in the serum could be used as a diagnostic marker for systemic sclerosis1) and reduced XylT activities in seminal plasma might be associated with infertile men2). In addition, it has been reported that genetic variations in the XylT-I are linked to the formation of abdominal aortic aneurysm, where GAG synthesis is altered3). In this section, the method for measurement of XylT activities using the synthetic bikunin analogous peptide Q-E-E-E-G-S-G-G-G-Q-K as an acceptor substrate is mentioned. Bikunin, the inhibitory component of the inter-a-trypsin inhibitor, is known to be glycosylated by a chondroitin sulfate chain4).
* It is suggested that XylT-I and XylT-II are, at least in vitro, functionally identical, because a soluble form of human XT-II expressed in the XylT-deficient pgsA-745 Chinese hamster ovary cell line is indeed capable of catalyzing the transfer of Xyl residue to a variety of peptide substrates. |
| Category | Glycosyltransferases & related proteins |
| Protocol Name | Enzyme assay of xylosyltransferase |
Authors
 |
Toshiyasu Koike
Department of Biochemistry, Kobe Pharmaceutical University
Satomi Nadanaka
Department of Biochemistry, Kobe Pharmaceutical University
Hiroshi Kitagawa
*
Department of Biochemistry, Kobe Pharmaceutical University
*To whom correspondence should be addressed.
|
| Keywords | proteoglycan
glycosaminoglycan
xylosyltransferase
glycosyltransferase |
Reagents
 |
| ● |
UDP-[14C]Xyl (PerkinElmer) |
| ● |
Synthetic peptide Q-E-E-E-G-S-G-G-G-Q-K (Invitrogen)*
* Synthetic peptides derived from APP (amyloid b A4 precursor protein) [T-E-N-E-G-S-G-L-T-N-I-K] and APLP2 (amyloid b A4 precursor-like protein 2) [S-E-N-E-G-S-G-M-A-E-Q-K] are also reported to be good substrates for XylT in vitro (5). |
|
Instruments
 |
| ● |
Superdex peptide HR 10/30 column (GE Healthcare) |
| ● |
2300TR liquid scintillation counter (PerkinElmer) |
|
| Methods |
|
1. |
Enzyme assay of XylT-I using the synthetic bikunin analogous peptide, Q-E-E-E-G-S-G-G-G-Q-K, as an acceptor.
|
| 1) |
The reaction mixture for XylT assays (a total volume of 40 μl) contains 10 μl of enzyme preparation (see Comment *), 25 mM MES buffer (pH 6.5), 25 mM KF, 5 mM MgCl2, 5 mM MnCl2, 2 mM UDP-[14C]Xyl (3.0 x 105 dpm), and the synthetic peptide Q-E-E-E-G-S-G-G-G-Q-K (10 nmol). |
Comment 1
|
|
| 2) |
The enzyme reaction is performed at 37˚C for 16 h. |
Comment 0
|
|
| 3) |
The 14C-labeled products are separated by gel filtration chromatography on a Superdex peptide column using 0.25 M ammonium bicarbonate containing 7% 1-propanol as the eluent at a flow rate of 0.4 ml/min. |
Comment 0
|
|
| 4) |
The collected fractions (0.4 ml each) are analyzed by liquid scintillation counter (Fig. 2). |
Comment 0
|
|
|
| Figure & Legends |
Figure & Legends


Fig. 1 Representative scheme for the initiation of GAG synthesis by XylT.
In mammals, UDP-Xyl is synthesized within the lumen of the ER/Golgi. XylT requires UDP-Xyl as a donor substrate. The GAG synthesis is initiated by transfer of a Xyl residue to specific serine residues in the core proteins by different XylTs (XylT-I and XylT-II). Next, GalT-I and GalT-II successively transfer two Gal residues. GlcAT-I completes the biosynthesis of the linkage region by transferring a GlcA residue. SLC35D1, Nucleotide sugar transporter to transport UDP-GlcA (ER membrane); SLC35B4, Nucleotide sugar transporter to transport UDP-Xyl (Golgi membrane); UXS1, UDP-Xyl synthase; GalT, galactosyltransferase; GlcAT, glucuronyltransferase.


Fig. 2 Gel filtration analysis of XylT-I reaction products.
14C-labelled reaction products were isolated by gel filtration chromatography on a Superdex peptide column using 0.25M ammonium bicarbonate containing 7% 1-propanol as the eluent at a flow rate of 0.4 ml/min. The separated fractions (0.4 ml each) were measured for radioactivities. Peaks: 1, Q-E-E-E-G-S([14C]Xyl)-G-G-G-Q-K ; 2, UDP- [14C]Xyl. |
| Copyrights |
Attribution-Non-Commercial Share Alike
This work is released underCreative Commons licenses
|
| Date of registration:2012-11-15 14:54:04 |
- Gotting, C., Sollberg, S., Kuhn, J., Weilke, C., Huerkamp, C., Brinkmann, T., Krieg, T., Kleesiek, K. Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis. J. Invest. Derm. 112, 919-924, 1999. [PMID : 10383739]
- Gotting, C., Kuhn, J., Brinkmann, T., Kleesiek, K. Xylosyltransferase activity in seminal plasma of infertile men. Clin. Chim. Acta 317, 199-202, 2002. [PMID : 11814476]
- Gotting C, Prante C, Schillinger M, Exner M, Domanovits H, Raith M, Kuhn J, Kleesiek K. Xylosyltransferase I variants and their impact on abdominal aortic aneurysms. Clin Chim Acta. 391, 41-5. 2008. [PMID : 18294457]
- Brinkmann, T., Weilke, C., and Kleesiek, K. Recognition of acceptor proteins by UDP-D-xylose proteoglycan core protein b-D-Xylosyltransferase. J. Biol. Chem. 272, 11171-11175, 1997. [PMID : 9111016]
- Gotting, C., Kuhn, J., Brinkmann, T., Kleesiek, K. Xylosylation of alternatively spliced isoforms of Alzheimer APP by xylosyltransferase. J. Prot. Chem. 17, 295-302, 1998. [PMID : 9588955]
|
This work is licensed under Creative Commons Attribution-Non-Commercial Share Alike. Please include the following citation
to Share (copy, distribute and transmit the text contents of the work):
This work was originally published in JCGGDB, GlycoPOD(84),
Koike,
Nadanaka,
Kitagawa,
" Enzyme assay of xylosyltransferase " 2012. http://jcggdb.jp/GlycoPOD/ © Ritsumeikan University, AIST & JCGGDB.
to Remix (adapt the text contents of the work):
This work was adapted from JCGGDB, GlycoPOD(84),
Koike,
Nadanaka,
Kitagawa,
" Enzyme assay of xylosyltransferase " 2012. http://jcggdb.jp/GlycoPOD/ © Ritsumeikan University, AIST & JCGGDB.
Including references that appeared in the References tab in your work is
much appreciated.
For those who wish to reuse the figures/tables, please contact JCGGDB
management office (jcggdb-ml@aist.go.jp).
|
|